Vemurafenib-induced DRESS/DIHS resulting in spontaneous melanoma regression: an immunological reaction shedding new light on melanoma treatment?

Int J Dermatol. 2020 May;59(5):e139-e141. doi: 10.1111/ijd.14852. Epub 2020 Mar 25.

Cristina Olteanu¹, Alon Scope², Yael Steinberg-Silman^{3

4}, Michael Ziv⁵, Neil H Shear^{6

7}, Roni P Dodiuk-Gad^{5

6}, Gal Markel^{3

4}

¹ Division of Dermatology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
² Medical Screening Institute, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel.
⁴ Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
⁵ Dermatology Department, Emek Medical Center, Bruce Rappaport Faculty of Medicine, Technion-Institute of Technology, Haifa, Israel.
⁶ Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
⁷ Division of Clinical Pharmacology and Toxicology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

No abstract available

Publication types